Method for screening active agents that stimulate the expression of CERT to improve the skin's barrier function
US9228999B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2010 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | Mar 19, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for screening an active agent intended for preventing or combating the cutaneous signs resulting from a non-pathological impairment of barrier function, which includes the selection of active agents that stimulate the expression of the ceramide transport protein CERT in cultured human keratinocytes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.